Cite
HARVARD Citation
Zare, N. et al. (2019). Evaluation of exosomal miR-155, let-7g and let-7i levels as a potential noninvasive biomarker among refractory/relapsed patients, responsive patients and patients receiving R-CHOP. Leukemia & lymphoma. 60 (8), pp. 1877-1889. [Online].